文献速递腹部CTMR

LI-RADS v2018分类与影像特征:增强CT、钆塞酸二钠增强MRI与细胞外对比剂增强MRI的模态间一致性

LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI.
PubMed 文献 · Radiol Med · 2024-08-19

该回顾性研究纳入96例肝硬化患者共144个观察灶,行CT、EOB-MRI或ECA-MRI中至少两种检查,采用LI-RADS v2018评估。三种模态对主要和辅助影像特征的检出无显著差异;全部观察灶中CT与EOB-MRI一致性为中等(k 0.60),CT与ECA-MRI为一般(k 0.46),EOB-MRI与ECA-MRI为中等(k 0.72);小于20 mm的观察灶一致性下降。以LR-5预测HCC时ECA-MRI敏感度70%、特异度100%。

要点

  • 小于20 mm的观察灶中,CT与EOB-MRI分类一致性仅fair(k 0.26),阅片报告需谨慎。
  • 全部观察灶中EOB-MRI与ECA-MRI分类一致性最高(k 0.72),CT与ECA-MRI最低(k 0.46)。
  • 以LR-5预测HCC时,ECA-MRI敏感度70%、特异度100%,为三种模态中最高。

核心结论

  • CT、ECA-MRI与EOB-MRI之间的模态间一致性在小于20 mm的观察灶中下降;ECA-MRI对HCC诊断提供了更高的敏感度。

研究设计与样本

  • 回顾性研究,纳入96例肝硬化患者共144个观察灶(平均大小34.0±32.4 mm),每例至少行CT、EOB-MRI或ECA-MRI中两种检查;由两名放射科医师按LI-RADS v2018评估;参考标准为病理证实及LI-RADS v2018影像标准。

关键影像表现/征象

  • 三种影像模态对主要和辅助影像特征的检出无显著差异。
  • 全部观察灶中,CT与EOB-MRI的LI-RADS分类一致性为中等(k 0.60;95%CI 0.44, 0.75)。
  • 全部观察灶中,CT与ECA-MRI的LI-RADS分类一致性为一般(k 0.46;95%CI 0.22, 0.69)。
  • 全部观察灶中,EOB-MRI与ECA-MRI的LI-RADS分类一致性为中等(k 0.72;95%CI 0.59, 0.85)。
  • 小于20 mm的观察灶中,CT与EOB-MRI一致性为fair(k 0.26;95%CI 0.05, 0.47),CT与ECA-MRI为中等(k 0.42;95%CI -0.02, 0.88),EOB-MRI与ECA-MRI为中等(k 0.65;95%CI 0.47, 0.82)。

诊断标准与关键数值

  • 以LR-5预测HCC时,ECA-MRI的敏感度为70%、特异度为100%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To perform an intra-individual comparison of LI-RADS category and imaging features in patients at high risk of hepatocellular carcinoma (HCC) on contrast-enhanced CT, gadoxetate disodium-enhanced MRI (EOB-MRI), and extracellular agent-enhanced MRI (ECA-MRI) and to analyze the diagnostic performance of each imaging modality.

METHOD: This retrospective study included cirrhotic patients with at least one LR-3, LR-4, LR-5, LR-M or LR-TIV observation imaged with at least two imaging modalities among CT, EOB-MRI, or ECA-MRI. Two radiologists evaluated the observations using the LI-RADS v2018 diagnostic algorithm. Reference standard included pathologic confirmation and imaging criteria according to LI-RADS v2018. Imaging features were compared between different exams using the McNemar test. Inter-modality agreement was calculated by using the weighted Cohen's kappa (k) test.

RESULTS: A total of 144 observations (mean size 34.0 ± 32.4 mm) in 96 patients were included. There were no significant differences in the detection of major and ancillary imaging features between the three imaging modalities. When considering all the observations, inter-modality agreement for category assignment was substantial between CT and EOB-MRI (k 0.60; 95%CI 0.44, 0.75), moderate between CT and ECA-MRI (k 0.46; 95%CI 0.22, 0.69) and substantial between EOB-MRI and ECA-MRI (k 0.72; 95%CI 0.59, 0.85). In observations smaller than 20 mm, inter-modality agreement was fair between CT and EOB-MRI (k 0.26; 95%CI 0.05, 0.47), moderate between CT and ECA-MRI (k 0.42; 95%CI -0.02, 0.88), and substantial between EOB-MRI and ECA-MRI (k 0.65; 95%CI 0.47, 0.82). ECA-MRI demonstrated the highest sensitivity (70%) and specificity (100%) when considering LR-5 as predictor of HCC.

CONCLUSIONS: Inter-modality agreement between CT, ECA-MRI, and EOB-MRI decreases in observations smaller than 20 mm. ECA-MRI has the provided higher sensitivity for the diagnosis of HCC.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Agnello F, Cannella R, Brancatelli G, et al. LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI. Radiol Med. 2024. PMID: 39158817. doi:10.1007/s11547-024-01879-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。